Device Trial Radar · NCT02546362
Cefaly® Device in the Treatment of Patients With Fibromyalgia.
Last checked: Nov 19, 2026Latest source record: Jul 19, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
50
Actual
Start
Dec 3, 2015
Primary completion
May 15, 2018
Study completion May 15, 2018
Sponsor
- Lead sponsor
- Cefaly TechnologyNot on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 10, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this pilot open trial was to assess the efficacy and safety of external trigeminal nerve stimulation (e-TNS) with the Cefaly® device in fibromyalgia.
Conditions
- Fibromyalgia
Interventions
CefalyDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Pain Intensity (Fibromyalgia Impact Questionnaire-revised (FIQR) Pain Score) Between Baseline and 12-week TimepointTime frame: between baseline and 12-week timepoint
- Change in Fibromyalgia Impact Questionnaire-revised (FIQR) Total Score Between Baseline and 12-week TimepointTime frame: between baseline and 12-week timepoint
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Cincinnati College of Medicine
Cincinnati, Ohio
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.